Clinical and pharmacological group: & nbsp

Potency regulators

Included in the formulation
АТХ:

G.04.B.E   Drugs for the treatment of erectile dysfunction

Pharmacodynamics:

Activates NO-synthase, increases the content of nitric oxide (NO) in the cavernous body, relaxes the muscles of the cavernous body, increases the blood flow in the penis during sexual stimulation.

Pharmacokinetics:

Not studied.

Indications:

It is used for lowering libido, erectile dysfunction, vegetative disorders in men's menopause.

V.F50-F59.F52.0   Absence or loss of sexual desire

V.F50-F59.F52.2   Insufficiency of the genital reaction

Contraindications:

Individual intolerance.

Carefully:

It is used with caution in individuals who have lactase deficiency, since lactose is present in the formulation.

Pregnancy and lactation:

Recommendations for FDA - not determined.

Dosing and Administration:

It is taken once in the amount of one tablet under the tongue until completely dissolved 15-20 minutes before meals and 1 hour before the alleged sexual intercourse - no more often 2-3 times a week. In the treatment of impotence and menopausal disorders, the course of treatment is 12 weeks and includes taking one tablet every other day.

With occasional use - 2 tablets 1-2 hours before sexual intercourse.

The highest daily dose: 2 tablets.

Side effects:

Allergic reactions.

Overdose:

Cases of overdose are not described.

Interaction:

Dissolving tablets are used outside meals. The drug is incompatible with cow's milk.

Allowed to take the drug in patients receiving nitrates, β-adrenoblockers, ACE inhibitors, diuretics, calcium antagonists.
Special instructions:

The drug is used according to the scheme for the treatment of vegetative disorders in men's menopause and occasionally - to increase erectile function. With the course of treatment, there is an increase in the number of androgens in the blood plasma.

Instructions
Up